MedPath

Glucose as a Mediator of Self-control Performances in Patients With Schizophrenia

Not Applicable
Conditions
Schizophrenia
Interventions
Dietary Supplement: glucose drink
Registration Number
NCT01563016
Lead Sponsor
The University of Hong Kong
Brief Summary

The research aims to investigate the relationship between self-control ability and blood glucose level in schizophrenic patients. The main purpose of the present study is to explore whether the close relationship of blood glucose and self-regulatory strength observed in healthy individuals, is applicable to schizophrenic patients. More specifically, the current study aims

* to investigate whether the exertion of self-control reduces blood glucose,

* to examine whether low level of blood glucose deteriorates subsequent self-control performances

* to examine whether restoring the glucose level eliminates these impairments, in schizophrenic patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Aged 15 or above
  • DSM-IV diagnosis of schizophrenia, schizoaffective disorder, schizophreniform psychosis, brief psychosis, psychosis NOS or delusional disorder
  • Cantonese-speaking Chinese
  • Ability to understand the nature of the study and sign informed consent
Exclusion Criteria
  • Organic Brain disorder
  • Known history of intellectual disability
  • Priority Follow Up (Subtarget or Target)
  • All allergic to any sugar or artificial sweeteners
  • Diabetics
  • Physical Disability

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Glucose & Depletingglucose drinkparticipants will perform in a depleting task and receive a glucose drink
Glucose & non-depletingglucose drinkparticipants will perform in a non-depleting task and receive a glucose drink
Primary Outcome Measures
NameTimeMethod
Blood Glucose Levelbaseline, after depleting task
self control tasks (handgrip, stroop, figure tracing task)after 12-minutes metabolizing phase
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The University of Hong Kong

🇨🇳

Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath